Insights on lentiviral transduction and cell therapy.
Articles, white papers, and scientific papers on transduction, manufacturing, and cell engineering — including the science and workflow advantages behind HiTE™.
Built for researchers, process teams, and cell therapy innovators.
Featured Articles
All articles →HiTE™ vs. Conventional Viral Transduction Enhancers: Efficiency, Safety, and Manufacturing Impact
Compare HiTE™ with retronectin, Polybrene, and LentiBOOST across efficiency, viability, VCN, and workflow impact in T cells, NK cells, and iPSCs.
Read article →NK Cell Lentiviral Transduction: Why It's Hard and How HiTE™ Helps
The biology that makes primary NK cells notoriously difficult to transduce, and how a TFP-based approach reshapes the math for CAR-NK programs.
Read article →How Better Transduction Reduces CAR-T Manufacturing Cost and Risk
Where transduction sits in CAR-T COGS, how vector consumption and yield variability drive cost, and what high-efficiency enhancement means for late-stage programs.
Read article →Browse by type
Articles
Educational and editorial pieces on transduction biology, manufacturing economics, and process design.
Browse articles → Expanding soonWhite Papers
In-depth technical white papers on HiTE™ and lentiviral transduction. The current HiTE™ white paper is available now; more are coming.
View white papers → Expanding soonScientific Papers
We'll list peer-reviewed publications that reference HiTE™ here as they're published.
See scientific papers →